A Phase 3 Study of Abatacept in Chinese Patients With Active Rheumatoid Arthritis and Inadequate Response to Methotrexate

Clinical trial NCT02722694 · UNKNOWN

Trial details

NCT number: NCT02722694
Sponsor: Jiangsu Simcere Pharmaceutical Co., Ltd.
Status: UNKNOWN
Phase: Phase 3
Study type: INTERVENTIONAL

Rheumatoid Arthritis (RA)

Start date: 2016-08-01
Primary completion: 2017-06-01
Enrollment: 360

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.